The Drug-Induced Respiratory Disease Website and App
Frequency - Incidence
Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases
Evidence level/grade
Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic
Bronchospasm - Wheezing - Asthma
Publications
Urticaria, angioedema and dyspnoea in adjuvant therapy of melanoma with interferon alpha-2b.
Acta dermato-venereologica 2010 May;90;308-9 — 2010 May — 308-9
Severe exacerbation of asthma: a new side effect of interferon-alpha in patients with asthma and chronic hepatitis C.
Mayo Clinic proceedings 1999 Apr;74;367-70 — 1999 Apr — 367-70